Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: Prognostic factors and treatment selection based on two large randomized clinical trials

Rogerio Lilenbaum, Victoria M. Villaflor, Corey Langer, Kenneth O'Byrne, Mary O'Brien, Helen J. Ross, Mark Socinski, Fred B. Oldham, Larissa Sandilac, Jack W. Singer, Philip Bonomi

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: Prognostic factors and treatment selection based on two large randomized clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences